Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS"
- PMID: 35213729
- PMCID: PMC9113816
- DOI: 10.1210/clinem/dgac111
Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS"
Keywords: bisphosphonates; bone metastases; denosumab; osteonecrosis of the jaw; osteoporosis.
Comment on
-
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888. J Clin Endocrinol Metab. 2022. PMID: 34922381 Free PMC article. Review.
-
Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS".J Clin Endocrinol Metab. 2022 May 17;107(6):e2646. doi: 10.1210/clinem/dgac109. J Clin Endocrinol Metab. 2022. PMID: 35213697 No abstract available.
References
-
- Campos-Staffico AM, Freitas WM, Carvalho LSF, Coelho-Filho OR, Nadruz W Jr., Oliveira RBAC; Brasilia Study on Healthy Aging and Brasilia Heart Study. Lower bone mass is associated with subclinical atherosclerosis, endothelial dysfunction and carotid thickness in the very elderly. Atherosclerosis. 2020;292:70-74. - PubMed
-
- Lampropoulos CE, Papaioannou I, D’Cruz DP. Osteoporosis--a risk factor for cardiovascular disease? Nat Rev Rheumatol. 2012;8(10):587-598. - PubMed
-
- Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Yavropoulou MP, Makras P. Postmenopausal osteoporosis coexisting with other metabolic diseases: treatment considerations. Maturitas. 2021;147:19-25. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
